INCLISIRAN, KJX839, Placebo to KJX839 (Inclisiran) 0 mg/1.5 mL Solution for injection in vial
CKJX839C12303
Phase 3 small_molecule active
Quick answer
INCLISIRAN, KJX839, Placebo to KJX839 (Inclisiran) 0 mg/1.5 mL Solution for injection in vial for Heterozygous Familial Hypercholesterolemia is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Heterozygous Familial Hypercholesterolemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active